These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15967937)

  • 1. Estrogen dermatitis: treatment with progestin-only pill.
    Randall K; Steele R
    Arch Dermatol; 2005 Jun; 141(6):792-3. PubMed ID: 15967937
    [No Abstract]   [Full Text] [Related]  

  • 2. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk.
    Maxwell GL; Schildkraut JM; Calingaert B; Risinger JI; Dainty L; Marchbanks PA; Berchuck A; Barrett JC; Rodriguez GC
    Gynecol Oncol; 2006 Nov; 103(2):535-40. PubMed ID: 16740300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in hormonal contraception.
    Erkkola R
    Curr Opin Obstet Gynecol; 2007 Dec; 19(6):547-53. PubMed ID: 18007132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Estrogen-progestin contraceptive use during adolescence prevents bone mass acquisition: a 4-year follow-up study.
    Schilling LH
    Contraception; 2009 Mar; 79(3):241; author reply 241-2. PubMed ID: 19185682
    [No Abstract]   [Full Text] [Related]  

  • 5. Pravastatin-induced lichenoid drug eruption.
    Pua VS; Scolyer RA; Barnetson RS
    Australas J Dermatol; 2006 Feb; 47(1):57-9. PubMed ID: 16405486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute generalized exanthematous pustulosis due to clindamycin.
    Sulewski RJ; Blyumin M; Kerdel FA
    Dermatol Online J; 2008 Jul; 14(7):14. PubMed ID: 18718198
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice. Combination estrogen-progestin oral contraceptives.
    Petitti DB
    N Engl J Med; 2003 Oct; 349(15):1443-50. PubMed ID: 14534338
    [No Abstract]   [Full Text] [Related]  

  • 8. Bullous fixed drug eruption (BFDE) following per-oral metronidazole.
    Sehgal VN; Khandpur S; Sardana K; Bajaj P
    J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):607-9. PubMed ID: 12941113
    [No Abstract]   [Full Text] [Related]  

  • 9. Violaceous plaques in a patient with acquired immunodeficiency syndrome.
    Bessinger GT; Conologue TD; Krivda SJ; Turiansky GW
    Arch Dermatol; 2003 Feb; 139(2):215-20. PubMed ID: 12588229
    [No Abstract]   [Full Text] [Related]  

  • 10. Vancomycin-associated neutrophilic dermatitis histologically mimicking Cryptococcus.
    Boyd AS; Ortleb M
    J Am Acad Dermatol; 2014 Apr; 70(4):e86-e88. PubMed ID: 24629371
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of estrogen and progestin potency of oral contraceptives with ovarian carcinoma risk.
    Lurie G; Thompson P; McDuffie KE; Carney ME; Terada KY; Goodman MT
    Obstet Gynecol; 2007 Mar; 109(3):597-607. PubMed ID: 17329510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen-progestin contraceptive use during adolescence prevents bone mass acquisition: a 4-year follow-up study.
    Pikkarainen E; Lehtonen-Veromaa M; Möttönen T; Kautiainen H; Viikari J
    Contraception; 2008 Sep; 78(3):226-31. PubMed ID: 18692613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined oral contraceptives for the treatment of acne: a practical guide.
    Arrington EA; Patel NS; Gerancher K; Feldman SR
    Cutis; 2012 Aug; 90(2):83-90. PubMed ID: 22988652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Backup contraception - past, current and future trends ].
    Tzvetanov D
    Akush Ginekol (Sofiia); 2008; 47 Suppl 2():13-9. PubMed ID: 19496449
    [No Abstract]   [Full Text] [Related]  

  • 15. [Venous pathology with estrogens-progestagens].
    Vin F; Allaert FA; Levardon M
    Phlebologie; 1989; 42(3):473-9; discussion 479-80. PubMed ID: 2626469
    [No Abstract]   [Full Text] [Related]  

  • 16. Headache and combination estrogen-progestin oral contraceptives: integrating evidence, guidelines, and clinical practice.
    Loder EW; Buse DC; Golub JR
    Headache; 2005 Mar; 45(3):224-31. PubMed ID: 15836597
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A high serum concentration of chemerin in pustular dermatitis paradoxically induced by etanercept.
    Sawada Y; Nakamura M; Hama K; Hino R; Tokura Y
    J Am Acad Dermatol; 2012 May; 66(5):e182-4. PubMed ID: 22507591
    [No Abstract]   [Full Text] [Related]  

  • 18. Symmetrical drug-related intertriginous and flexural exanthema (SDRIFE) induced by golimumab.
    Yang SY; Lan CC; Hu SC
    Int J Dermatol; 2017 May; 56(5):571-572. PubMed ID: 28217835
    [No Abstract]   [Full Text] [Related]  

  • 19. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pseudoporphyria induced by oral contraceptive pills.
    Silver EA; Silver AH; Silver DS; McCalmont TH
    Arch Dermatol; 2003 Feb; 139(2):227-8. PubMed ID: 12588238
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.